Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry

Altres autors/es

[Rudilosso S] Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain. Clinical and Experimental Neuroscience: Cerebrovascular Diseases, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Ríos J] Medical Statistics Core Facility, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Hospital Clinic, Barcelona, Spain. Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Barcelona, Spain. [Rodríguez A, Vera V] Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain. [Gomis M] Stroke Unit, Department of Neuroscience, Germans Trias Hospital, Badalona, Spain. [Gómez-Choco M] Department of Neurology, Moisès-Broggi Hospital, Sant Joan Despí, Spain. [Molina C] Unitat d’Ictus, Servei de Neurologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Cocho D] Department of Emergency, Hospital General de Granollers, Granollers, Spain. [Terceño M, Serena J] Servei de Neurologia, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain

Departament de Salut

Data de publicació

2022-02-22T12:37:14Z

2022-02-22T12:37:14Z

2021-09-30



Resum

Stroke; Thrombectomy; Prognosis


Ictus; Trombectomia; Pronòstic


Ictus; Trombectomía; Pronóstico


Background and purpose: In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors. Methods: Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, National Institutes of Health Stroke Scale [NIHSS] >25, time from onset >6 hours, Alberta Stroke Program Early CT Score <6, proximal vertebrobasilar occlusion, supratherapeutic international normalized ratio >3), good (if NIHSS <6 or distal occlusion, in the absence of poor prognostic factors), or reference (not meeting other groups' criteria). Results: Patients receiving MT (n=1,996, 77%) were younger, had less pre-stroke disability, and received systemic thrombolysis less frequently. These differences were balanced after the IPTW stratified by prognosis. MT was associated with good functional outcome in the reference (odds ratio [OR], 2.9; 95% confidence interval [CI], 2.0 to 4.4), and especially in the poor baseline prognostic stratum (OR, 3.9; 95% CI, 2.6 to 5.9), but not in the good prognostic stratum. MT was associated with survival only in the poor prognostic stratum (OR, 2.6; 95% CI, 2.0 to 3.3). Conclusions: Despite their worse overall outcomes, the impact of thrombectomy over medical management was more substantial in patients with poorer baseline prognostic factors than patients with good prognostic factors.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Korean Stroke Society

Documents relacionats

Journal of stroke;23(3)

https://doi.org/10.5853/jos.2021.00962

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution-NonCommercial 4.0 International

http://creativecommons.org/licenses/by-nc/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)